Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hereditary angioedema
Marketing
New HAE drugs from Takeda, BioCryst are gaining popularity
Orladeyo’s growth will mainly come at the expense of CSL’s Berinert and Haegarda, while Takeda’s Takhzyro will also gain share, one analyst says.
Angus Liu
Mar 18, 2022 11:16am
Samsung, Moderna, Brii and more—Fierce Pharma Asia
Aug 27, 2021 9:20am
ICER is urging steep discounts on Takeda and CSL drugs
Aug 24, 2021 2:18pm
Sinopharm, Sinovac, Astellas, BGI and more—Fierce Pharma Asia
Jul 16, 2021 8:50am
Can durability data keep Takeda's Takhzyro in control in HAE?
Jul 12, 2021 12:59pm
Fueled by patient insights, BioCryst's HAE launch takes flight
May 25, 2021 4:51pm
